Prelude Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-1,013
| Closed | -$249K | – | 1709 |
|
2022
Q3 | $249K | Sell |
1,013
-1,830
| -64% | -$450K | 0.01% | 941 |
|
2022
Q2 | $704K | Buy |
+2,843
| New | +$704K | 0.02% | 543 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 1753 |
|
2020
Q3 | – | Sell |
-262
| Closed | -$63K | – | 2006 |
|
2020
Q2 | $63K | Buy |
+262
| New | +$63K | ﹤0.01% | 767 |
|
2020
Q1 | – | Sell |
-565
| Closed | -$96K | – | 1726 |
|
2019
Q4 | $96K | Buy |
+565
| New | +$96K | ﹤0.01% | 754 |
|
2019
Q2 | – | Sell |
-156
| Closed | -$45K | – | 1835 |
|
2019
Q1 | $45K | Sell |
156
-381
| -71% | -$110K | ﹤0.01% | 814 |
|
2018
Q4 | $175K | Buy |
+537
| New | +$175K | 0.01% | 539 |
|
2018
Q3 | – | Sell |
-38
| Closed | -$16K | – | 1770 |
|
2018
Q2 | $16K | Sell |
38
-374
| -91% | -$157K | ﹤0.01% | 1120 |
|
2018
Q1 | $120K | Sell |
412
-209
| -34% | -$60.9K | 0.01% | 727 |
|
2017
Q4 | $116K | Buy |
621
+16
| +3% | +$2.99K | 0.01% | 670 |
|
2017
Q3 | $102K | Sell |
605
-109
| -15% | -$18.4K | 0.01% | 795 |
|
2017
Q2 | $102K | Buy |
+714
| New | +$102K | 0.01% | 699 |
|
2016
Q4 | – | Sell |
-607
| Closed | -$78K | – | 1788 |
|
2016
Q3 | $78K | Buy |
607
+20
| +3% | +$2.57K | 0.01% | 848 |
|
2016
Q2 | $64K | Buy |
+587
| New | +$64K | 0.01% | 869 |
|
2015
Q2 | – | Sell |
-1,427
| Closed | -$102K | – | 2037 |
|
2015
Q1 | $102K | Buy |
1,427
+127
| +10% | +$9.08K | 0.01% | 956 |
|
2014
Q4 | $49K | Hold |
1,300
| – | – | 0.01% | 1167 |
|
2014
Q3 | $32K | Hold |
1,300
| – | – | ﹤0.01% | 1518 |
|
2014
Q2 | $33K | Hold |
1,300
| – | – | ﹤0.01% | 1459 |
|
2014
Q1 | $34K | Hold |
1,300
| – | – | ﹤0.01% | 1358 |
|
2013
Q4 | $35K | Buy |
+1,300
| New | +$35K | 0.01% | 1119 |
|